Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advices EQT VIII in connection with the acquisition of Recover Nordic
Mandate

Vinge advises EQT VIII in connection with the acquisition of Recover Nordic

December 10, 2019 M&A

Vinge has advised EQT VIII in connection with the acquisition of Recover Nordic from funds advised by Agilitas Private Equity.

Recover Nordic is a Nordic market leader in property remediation and environmental services, primarily serving insurance companies, municipalities, industrial- and commercial clients. Headquartered in Oslo, Norway and with more than 90 branches across the Nordics, the Company has over 2,100 employees and is expected to generate revenues of NOK 3.0 billion in 2019.

The transaction is expected to close in the first quarter of 2020.

Vinge’s team consisted of Daniel Rosvall, Johanna Wiberg, Christian Brelin and Ellinor Wargenbrant (M&A), Johan Cederblad and Cornelia Medrek (Environment), Josefine Lanker and Axel Jansson (Banking and Financing), Mathilda Persson, Rebecka Maltenius, Martin Boström and Lisa Hörnqvist (Commercial Agreements and IT), Emma Johansson (Competition and Regulatory), Lisa Ullman and Ebba Svenburg (Employment) and Kristoffer Larson (Real Property).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026